Get the Stockscreener App
4.04
0.49%
0.02
Alpha Tau Medical Ltd stock is traded at $4.04, with a volume of 13,269.
It is up +0.49% in the last 24 hours and up +3.03% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
See More
Previous Close:
$4.06
Open:
$4.1
24h Volume:
13,269
Relative Volume:
0.21
Market Cap:
$347.87M
Revenue:
-
Net Income/Loss:
$-29.64M
P/E Ratio:
-9.3953
EPS:
-0.43
Net Cash Flow:
$-39.43M
1W Performance:
+2.77%
1M Performance:
+3.03%
6M Performance:
+45.19%
1Y Performance:
+36.00%
1-Day Range:
$4.0008
$4.1571
1-Week Range:
$3.67
$4.28
52-Week Range:
$2.30
$4.69
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
4.0799 | 346.17M | 0 | -29.64M | -39.43M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.20 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
730.81 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.51 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
913.71 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.82 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Will Alpha Tau Medical Ltd. Equity Warrant stock outperform international peersMarket Risk Analysis & Real-Time Volume Trigger Notifications - Newser
Is Alpha Tau Medical Ltd. Equity Warrant stock a smart buy before Fed meeting2025 Technical Overview & Reliable Breakout Forecasts - Newser
Why Alpha Tau Medical Ltd. Equity Warrant stock is popular among millennialsMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Alpha Tau Medical Ltd. stock rally after Fed decisionsJuly 2025 Outlook & Stock Portfolio Risk Management - Newser
Alpha Tau announces two Alpha DaRT abstracts at ASCO Symposium - TipRanks
Alpha Tau Medical to Present Pancreatic Cancer Research at 2026 ASCO Symposium - TipRanks
Alpha Tau Announces Presentation of Two Alpha DaRT - GlobeNewswire
How Alpha Tau Medical Ltd. stock benefits from global expansionMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Alpha Tau Medical Ltd. Receives FDA Approval to Initiate A Trial for Patients with Locally Recurrent Prostate Cancer - marketscreener.com
Alpha Tau receives FDA approval to initiate a trial for patients with locally recurrent prostate cancer - marketscreener.com
Alpha Tau Medical Receives FDA Approval for Prostate Cancer Trial - TipRanks
Alpha Tau receives FDA approved IDE application to initiate study of Alpha DaRT - TipRanks
Alpha Tau (NASDAQ: DRTS) gains FDA IDE to test Alpha DaRT in recurrent prostate cancer - Stock Titan
Alpha Tau to Participate in December Investor Conferences - The Manila Times
What insider trading reveals about Alpha Tau Medical Ltd. stockJuly 2025 Momentum & Safe Capital Growth Stock Tips - moha.gov.vn
What is HC Wainwright’s Forecast for DRTS FY2025 Earnings? - Defense World
Alpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC Wainwright - Defense World
Promising Developments and Strategic Trials Support Buy Rating for Alpha Tau Medical Ltd. - TipRanks
HC Wainwright & Co. Reiterates Alpha Tau Medical (DRTS) Buy Recommendation - MSN
Alpha Tau Medical Reports Q3 2025 Progress and Financials - MSN
Alpha Tau reports Q3 EPS (32c), consensus (12c) - MSN
Alpha Tau Eyes Year-End Japanese Clearance For Alpha DaRT Treatment In Recurrent Head & Neck Cancer - Nasdaq
Alpha Tau Medical Reports Q3 2025 Results and Advances in Cancer Therapy - TipRanks
[6-K] Alpha Tau Medical Ltd. Current Report (Foreign Issuer) | DRTS SEC FilingForm 6-K - Stock Titan
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
How sustainable is Alpha Tau Medical Ltd. Equity Warrant stock dividend payoutMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock performs in high volatility marketsJobs Report & Daily Entry Point Trade Alerts - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock responds to policy changesMarket Performance Summary & Capital Protection Trading Alerts - newser.com
Is Alpha Tau Medical Ltd. stock a defensive play in 2025Trade Analysis Report & Risk Controlled Daily Trade Plans - newser.com
Applying Elliott Wave Theory to Alpha Tau Medical Ltd. Equity WarrantJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Relative strength of Alpha Tau Medical Ltd. in sector analysis2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Published on: 2025-11-19 15:11:14 - newser.com
How Alpha Tau Medical Ltd. Equity Warrant stock performs in rising dollar environmentShare Buyback & Scalable Portfolio Growth Ideas - newser.com
Heatmap analysis for Alpha Tau Medical Ltd. Equity Warrant and competitorsJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
Will Alpha Tau Medical Ltd. Equity Warrant stock benefit from sector rotation2025 Key Highlights & Smart Money Movement Alerts - newser.com
Published on: 2025-11-19 05:24:32 - newser.com
Alpha Tau Medical Ltd. Equity Warrant stock prediction for this weekIndex Update & Reliable Price Breakout Alerts - newser.com
How to forecast Alpha Tau Medical Ltd. Equity Warrant trends using time series - newser.com
Published on: 2025-11-19 00:19:53 - newser.com
Is Alpha Tau Medical Ltd. stock undervalued vs historical averagesM&A Rumor & Verified Swing Trading Watchlists - newser.com
Published on: 2025-11-18 18:09:39 - newser.com
Will Alpha Tau Medical Ltd. outperform the marketWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Bassett Among First to Participate in Pancreatic Cancer Clinical Trial - WIBX 950
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):